High‐Dose Cyclophosphamide in the Treatment of Multiple Sclerosis von Schwartzman, Robert Jay, Simpkins, Nicole, Alexander, Guillermo M., Reichenberger, Erin, Ward, Kristine, Lindenberg, Noah, Topolsky, David, Crilley, Pam

Volltext

Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study von Alva, Ajjai S, Mangat, Pam K, Garrett-Mayer, Elizabeth, Halabi, Susan, Hansra, Damien, Calfa, Carmen J, Khalil, Maged F, Ahn, Eugene R, Cannon, Timothy L, Crilley, Pamela, Fisher, Julie G, Haslem, Derrick S, Shrestha, Sagun, Antonelli, Kaitlyn R, Butler, Nicole L, Warren, Sasha L, Rygiel, Andrew L, Ranasinghe, Shamika, Bruinooge, Suanna S, Schilsky, Richard L

Volltext

Cetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Profiling Utiliz... von Fisher, Julie G., Tait, David, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Schink, Julian C., Alvarez, Ricardo H., Veljovich, Dan, Cannon, Timothy L., Crilley, Pamela A., Pollock, Theodore, Calfa, Carmen J., Al Baghdadi, Tareq, Thota, Ramya, Fleming, Nicole, Cotta, Jared A., Rygiel, Andrew L., Warren, Sasha L., Schilsky, Richard L.

Volltext

Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF mutations: Results from the Targete... von Fisher, Julie, Garrett-Mayer, Elizabeth, Halabi, Susan, Mangat, Pam K., Alvarez, Ricardo H., Cannon, Timothy L., Crilley, Pamela, Pollock, Theodore, Baghdadi, Tareq Al, Cotta, Jared A., Rygiel, Andrew L., Antonelli, Kaitlyn R., Islam, Samiha, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Palbociclib (P) in patients (pts) with non-small cell lung cancer (NSCLC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study von Ahn, Eugene R, Mangat, Pam K., Garrett-Mayer, Elizabeth, Halabi, Susan, Dib, Elie G., Haggstrom, Daniel Ernest, Alguire, Kathryn B., Alvarez, Ricardo H., Calfa, Carmen Julia, Cannon, Timothy Lewis, Crilley, Pamela A., Gaba, Anu G., Marr, Alissa S., Sangal, Ashish, Thota, Ramya, Antonelli, Kaitlyn R., Islam, Samiha, Rygiel, Andrew Lawrence, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext

Pembrolizumab (P) in patients (pts) with metastatic breast cancer (MBC) with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry... von Alva, Ajjai Shivaram, Mangat, Pam K., Garrett-Mayer, Elizabeth, Halabi, Susan, Alvarez, Ricardo H., Calfa, Carmen Julia, Khalil, Maged F., Ahn, Eugene R, Cannon, Timothy Lewis, Crilley, Pamela A., Fisher, Julie Gottlieb, Haslem, Derrick S., Shrestha, Sagun, Antonelli, Kaitlyn R., Butler, Nicole L., Warren, Sasha L., Rygiel, Andrew Lawrence, Ranasinghe, Shamika, Bruinooge, Suanna S., Schilsky, Richard L.

Volltext